Biotech's 10 Biggest PR Disasters of 2012
By GMWatch,
GMWatch
| 12. 31. 2012
The 10 biggest GMO PR disasters of 2012
[For links, please refer to the original article here]
2012 was the year the lights came up on the biotech industry. Its claims, its tactics and its products all came under scrutiny and some of its biggest PR fairytales bit the dust. Here are some prime examples.
1. Fleeing Europe: The biotech bubble needs to appear to be constantly expanding but in early 2012 came the news that the GM and chemicals giant BASF was pulling its GM division out of Europe because it was facing opposition "from the majority of consumers, farmers and politicians." BASF also announced it was stopping the commercialization of its GM Amflora potato, one of only two GM crops authorized for cultivation in the European Union. The crop had been a commercial flop. The industry's only other crop grown in Europe, Monsanto's Mon810 GM maize, continued to face bans in a number of countries including France and Germany. Even GM crop trials are in decline and with BASF quitting Europe they're expected to decline still further...
Related Articles
By Matthew Herper, Stat | 07.01.2026
Researchers have created what they say may count as the first synthetic cell, and have started a public benefit corporation to share the technology with other scientists. It’s a piece of science that generates as many questions as answers. They...
By Darren Incorvaia, Fierce Biotech | 07.16.2026
Jennifer Doudna, Ph.D., the Nobel Laureate best known for co-inventing the CRISPR system that has become the foundation for gene editing, is dipping her toes into a new, buzzy field: AI-powered protein design.
In a new paper, published today...
By Emily Baumgaetner Nunn, The New York Times | 07.20.2026
The National Institutes of Health recently announced a remarkable achievement: the world’s largest database of human genomes, a repository of information that the agency says will help usher in a new era in personalized medicine.
Scientists are already developing clinical...
By Emily Packard Dawson and Lainie Friedman Ross , The Hastings Center for Bioethics | 07.16.2026
Major news outlets recently reported – based on a bioRxiv preprint – that scientists had edited genes in human embryos with “startling precision.” The scientists’ decision to release this work ahead of peer review, coupled with the extensive media coverage...
